169 related articles for article (PubMed ID: 35672846)
1. Exploring the mechanism and experimental verification of puerarin in the treatment of endometrial carcinoma based on network pharmacology and bioinformatics analysis.
Lin Z; Sui X; Jiao W; Wang Y; Zhao J
BMC Complement Med Ther; 2022 Jun; 22(1):150. PubMed ID: 35672846
[TBL] [Abstract][Full Text] [Related]
2. Construction of a prognostic model of luteolin for endometrial carcinoma.
Zhao J; Jiao W; Sui X; Zou J; Wang J; Lin Z
Am J Transl Res; 2023; 15(3):2122-2139. PubMed ID: 37056832
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer.
Zhou H; Chen L; Lei Y; Li T; Li H; Cheng X
Curr Probl Cancer; 2021 Apr; 45(2):100660. PubMed ID: 33012523
[TBL] [Abstract][Full Text] [Related]
4. Exploration of the Effect and Potential Mechanism of Echinacoside Against Endometrial Cancer Based on Network Pharmacology and in vitro Experimental Verification.
Shu W; Wang Z; Zhao R; Shi R; Zhang J; Zhang W; Wang H
Drug Des Devel Ther; 2022; 16():1847-1863. PubMed ID: 35734366
[TBL] [Abstract][Full Text] [Related]
5. MiRNA based tumor mutation burden diagnostic and prognostic prediction models for endometrial cancer.
Lu N; Liu J; Ji C; Wang Y; Wu Z; Yuan S; Xing Y; Diao F
Bioengineered; 2021 Dec; 12(1):3603-3620. PubMed ID: 34252354
[TBL] [Abstract][Full Text] [Related]
6. Identification of Five m6A-Related lncRNA Genes as Prognostic Markers for Endometrial Cancer Based on TCGA Database.
Shan L; Lu Y; Xiang CC; Zhu X; Zuo ED; Cheng X
J Immunol Res; 2022; 2022():2547029. PubMed ID: 35571565
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Tetrandrine Against Endometrial Cancer Based on Network Pharmacology.
Shang W; Zhang J; Song H; Zhu S; Zhang A; Hua Y; Han S; Fu Y
Drug Des Devel Ther; 2021; 15():2907-2919. PubMed ID: 34262258
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
Wang P; Zeng Z; Shen X; Tian X; Ye Q
DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive bioinformatics analysis of acquired progesterone resistance in endometrial cancer cell line.
Li W; Wang S; Qiu C; Liu Z; Zhou Q; Kong D; Ma X; Jiang J
J Transl Med; 2019 Feb; 17(1):58. PubMed ID: 30813939
[TBL] [Abstract][Full Text] [Related]
10. Exploring potential targets of Actinidia chinensis Planch root against hepatocellular carcinoma based on network pharmacology and molecular docking and development and verification of immune-associated prognosis features for hepatocellular carcinoma.
Qu M; Han T; Chen X; Sun Q; Li Q; Zhao M
J Gastrointest Oncol; 2022 Jun; 13(3):1289-1307. PubMed ID: 35837167
[TBL] [Abstract][Full Text] [Related]
11. Clinical value screening, prognostic significance and key pathway identification of miR-204-5p in endometrial carcinoma: A study based on the Cancer Genome Atlas (TCGA), and bioinformatics analysis.
Guo S; Yang J; Wu M; Xiao G
Pathol Res Pract; 2019 May; 215(5):1003-1011. PubMed ID: 30910254
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.
Li N; Yu K; Lin Z; Zeng D
Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanism of Puerariae Lobatae Radix in treatment of hepatocellular carcinoma based on network pharmacology].
Min Z; Yuan Z; Ye C; Nan XU; Wei-Bing LI; Cheng-Yu WU; Yan C
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4089-4098. PubMed ID: 33164393
[TBL] [Abstract][Full Text] [Related]
14. A 7-lncRNA signature predict prognosis of Uterine corpus endometrial carcinoma.
Ouyang D; Li R; Li Y; Zhu X
J Cell Biochem; 2019 Oct; 120(10):18465-18477. PubMed ID: 31168849
[TBL] [Abstract][Full Text] [Related]
15. An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer.
Zhang J; Wang Z; Zhao R; An L; Zhou X; Zhao Y; Wang H
BMC Cancer; 2020 Oct; 20(1):1030. PubMed ID: 33109128
[TBL] [Abstract][Full Text] [Related]
16. The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer.
Liu W; Sun L; Zhang J; Song W; Li M; Wang H
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33782686
[TBL] [Abstract][Full Text] [Related]
17. Mechanism investigation and experiment validation of capsaicin on uterine corpus endometrial carcinoma.
Lin Z; Sui X; Jiao W; Chen C; Zhang X; Zhao J
Front Pharmacol; 2022; 13():953874. PubMed ID: 36210802
[No Abstract] [Full Text] [Related]
18. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
19. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
20. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
Zhang Q; Xia T; Qi C; Du J; Ye C
BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]